Voyageur Pharmaceuticals's total assets for Q4 2025 were C$3.11M, a decrease of -15.58% from the previous quarter. VYYRF total liabilities were C$1.85M for the fiscal quarter, a -17.11% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.